(BOCT) Innovator SP500 Buffer - Overview
Etf: S&P500, Options, Buffer, ETF
| Risk 5d forecast | |
|---|---|
| Volatility | 11.4% |
| Relative Tail Risk | 1.62% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.65 |
| Alpha | 0.86 |
| Character TTM | |
|---|---|
| Beta | 0.685 |
| Beta Downside | 0.705 |
| Drawdowns 3y | |
|---|---|
| Max DD | 13.61% |
| CAGR/Max DD | 1.06 |
Description: BOCT Innovator SP500 Buffer December 31, 2025
The Innovator S&P 500 Buffer October (BATS: BOCT) is a non-diversified, defined-outcome ETF that, per Rule 35d-1 of the 1940 Act, must allocate at least 80 % of its net assets (plus any investment-purpose borrowings) to the SPDR® S&P 500® ETF Trust, which serves as its sole underlying exposure.
Key quantitative points to watch: the fund’s expense ratio sits around 0.70 % (higher than the underlying SPDR S&P 500 ETF’s ~0.09 % due to the buffer structure), the October buffer aims to absorb up to ~7 % downside risk while capping upside at roughly 8 % for the calendar year, and its assets under management (AUM) have grown to approximately $1.2 billion, reflecting investor appetite for capital-preservation strategies in volatile markets.
Macro-level drivers that will likely influence performance include U.S. GDP growth trends, Federal Reserve interest-rate policy (which affects equity valuations and the cost of borrowing for leveraged exposure), and sector weightings within the S&P 500-particularly the technology and consumer discretionary segments that dominate the index’s upside potential.
For a deeper, data-driven breakdown of BOCT’s risk-return profile, you might explore the analytics platform ValueRay, which aggregates real-time metrics and scenario analyses.
What is the price of BOCT shares?
Over the past week, the price has changed by -0.50%, over one month by +0.18%, over three months by +1.82% and over the past year by +12.71%.
Is BOCT a buy, sell or hold?
What are the forecasts/targets for the BOCT price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 56.3 | 12.9% |
BOCT Fundamental Data Overview February 04, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 315.2m USD (315.2m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 315.2m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 315.2m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 8.44% (E(315.2m)/V(315.2m) * Re(8.44%) + (debt-free company))
Discount Rate = 8.44% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)